Lupus tumidus induced by bortezomib not requiring discontinuation of the drug.
作者信息
Aguayo-Leiva I, Vano-Galvan S, Carrillo-Gijon R, Jaén-Olasolo P
出版信息
J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1363-4. doi: 10.1111/j.1468-3083.2010.03643.x.
Abstract
摘要
相似文献
1
Lupus tumidus induced by bortezomib not requiring discontinuation of the drug.
J Eur Acad Dermatol Venereol. 2010 Nov;24(11):1363-4. doi: 10.1111/j.1468-3083.2010.03643.x.
2
Bortezomib-induced lupus erythematosus tumidus.
Oncologist. 2009 Jun;14(6):637-9. doi: 10.1634/theoncologist.2008-0197. Epub 2009 May 27.
3
Bortezomib-induced cutaneous lupus in a patient with myeloma.
J Dermatol. 2013 Feb;40(2):123-4. doi: 10.1111/1346-8138.12015. Epub 2012 Oct 18.
4
Bortezomib-induced skin eruption.
Dermatology. 2008;216(2):156-8. doi: 10.1159/000111513. Epub 2008 Jan 23.
5
Adenovirus-associated hemorrhagic cystitis in a patient with plasma cell myeloma treated with bortezomib.
Leuk Res. 2009 Aug;33(8):e106. doi: 10.1016/j.leukres.2009.02.021. Epub 2009 Mar 13.
6
Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma.
Cutan Ocul Toxicol. 2009;28(3):141-3. doi: 10.1080/15569520903046934.
7
Cutaneous lesion induced by a subcutaneous administration of bortezomib.
Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):284-6. doi: 10.1016/j.clml.2012.05.002. Epub 2012 May 24.
8
Bortezomib-related diffuse alveolar hemorrhage.
J Clin Oncol. 2012 Dec 20;30(36):e379-81. doi: 10.1200/JCO.2012.43.6519. Epub 2012 Nov 13.
9
[Clinical development of a proteasome inhibitor, bortezomib, for the treatment of myeloma and lymphoma].
Rinsho Ketsueki. 2007 Jun;48(6):451-7.
10
Bortezomib.
Clin J Oncol Nurs. 2003 Nov-Dec;7(6):687-9. doi: 10.1188/03.CJON.687-689.
引用本文的文献
1
Lupus erythematosus tumidus: clinical perspectives.
Clin Cosmet Investig Dermatol. 2019 Oct 1;12:707-719. doi: 10.2147/CCID.S166723. eCollection 2019.
Zotero 插件